Portfolio company
Synthekine
United States · £84.9m raised
Raised
£84.9m
Latest stage
Series B
Rounds recorded
1
Backed by
3 investors
Sectors
About
This company develops engineered cytokine therapeutics and protein engineering platforms for patients with cancer and autoimmune or inflammatory diseases.
SourceFunding history · 1
Similar companies
Bright Peak Therapeutics
This biotechnology company develops engineered cytokine immunotherapies and immunoconjugates to treat patients with cancer and autoimmune diseases.
Simcha Therapeutics
The company develops engineered cytokine therapies for patients with cancer and various hematological conditions.
Synteny Biotechnology
The company develops generative AI platforms to design programmable protein therapeutics and precision immunology treatments for biotechnology researchers and pharmaceutical developers.
Synteny
This company develops AI-based bioinformatic solutions and programmable protein therapeutics to help pharmaceutical and biotechnology firms discover treatments for immune-driven diseases.
Evozyne
The company creates synthetic therapeutic proteins using generative artificial intelligence for pharmaceutical and biotechnology organisations to treat immune-mediated diseases and genetic disorders.
Hummingbird Bioscience
This company develops antibody-based therapeutics and drug conjugates for patients with hard-to-treat cancers and autoimmune diseases.
Modulus Therapeutics
This company develops engineered NK-cell therapies for autoimmune disease patients using a generative design and rapid prototyping platform.
SynsoryBio
SynsoryBio develops protein therapeutics designed to sense specific disease markers and activate only at targeted tissues to treat cancer and autoimmune disorders.
